Nanopore sequencing and its application to pandemic epidemiological survey of SARS CoV-19 and strains surveillance. Now, with COVID therapeutic manufacturing taking priority, there is a big desire to accelerate other clinical pipeline because of ample opportunity for new medicine.

MarketsandMarkets is proud to announce the Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23-24 September 2021 will hold discussions on trending technologies and its applications, challenges of implying these technologies into clinical specimen, practice of sequencing in healthcare domain specifically to cancer cells, overview of the data used in these technologies and its applications. This event will witness an overwhelming participation of leading healthcare and industry decision makers.

The paints & coatings market is expected to be a $179 billion market in 2025. The growth of end-use industries such as architectural, general industrial, protective, and automotive & transportation is driving the paints & coatings market growth.
A host of attractive, high growth opportunities such as Smart Coatings, NanoCoatings, Anti-Icing Coating, anti-microbial coatings, polyurea coatings, UV coatings, etc could be pursued. Participants such as Paints & Coatings Manufacturer, Resin, Solvent, and Additives manufacturers can benefit from this unprecedented growth over the next 5 years.

The adhesives market is expected to be a $70 billion market in 2025. The major drivers for the market are increased demand for adhesives in the medical industry, increasing demand for adhesives & sealants from the building & construction industry, and growth in the appliances industry.

A host of attractive, high growth opportunities such as EV Adhesives, Electronic Adhesives, medical adhesives, etc could be pursued. Participants such as Adhesives Manufacturer, Resin, Curing Agent, Additives & fillers manufacturers can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the Paints & Coatings  ecosystem, as seen through the lens of eminent CXOs in this space.

The pandemic has disrupted healthcare systems frameworks around the world, with hospitals be-ing overwhelmed due to the increasing influx of patients. The spread of COVID-19 has prodded a surge in demand for cleaning and disinfection products due to the growing awareness about hy-giene, health, and safety.

The utilization of reprocessed equipment to disinfect or sterilize medical devices is higher than normal now since improper decontamination of surgical instruments, endoscopic devices, respira-tory care devices, and reusable hemodialysis machines can increase the chances of healthcare as-sociated infections. Patient-to-patient pathogen transmission via medical devices can be entirely prevented by properly sterilising medical devices

Market intelligence provides a comprehensive perspective of any industry’s depth, both economically and philosophically. Organizations cannot afford to scrimp on acquiring market knowledge in today’s fast-paced economy. Missing up on these advantages can be the difference between success and failure.

The pandemic has disrupted healthcare systems frameworks around the world, with hospitals being overwhelmed due to the increasing influx of patients. The spread of COVID-19 has prodded a surge in demand for cleaning and disinfection products due to the growing awareness about hygiene, health, and safety. The increasing healthcare expenditure in North America being the major factor driving the demand and uptake of antiseptics and disinfectants in the region.

The utilization of reprocessed equipment to disinfect or sterilize medical devices is higher than normal now since improper decontamination of surgical instruments, endoscopic devices, respiratory care devices, and reusable hemodialysis machines can increase the chances of healthcare associated infections. Patient-to-patient pathogen transmission via medical devices can be entirely prevented by properly sterilizing medical devices.

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

More than just a term, Mergers and Acquisition process encompasses far more complex procedures and after transaction challenges. Numerous challenges like cultural fit, integration, infrastructure, etc. has led organizations to adopt a more clear and strategic approach to these MnA transactions. These challenges not only force the organization to bring changes to their business process but also mission and vision of the stakeholders.

MarketsandMarkets is proud to announce the 5th Edition Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference to be held on October 20-22, 2021. The expanding utilization of Real World Evidence to speed up data driven choices is further developing the clinical trial experience, but healthcare in general. 

While there is extraordinary promise in utilizing Real World Data and Real World Evidence, there are some significant challenges that should be survived: potential bias of information and data sources, inadequate data sets and absence of harmonization of data between RWE data sources, access to such data, and lack of standards in evaluating the worth of Real World Evidence data. Further developing RWE is key for pharma organizations in drug development. There was big data available pre covid and now with the access data due to covid, technology enablers like AI and ML are important for big data analysis and evidence generation. Every stakeholder has faced a some impact and had to adjust. 

The businesses have witnessed changes like never before and so do the Marketing world. It has become imperative for professionals to change the way of thinking and analyze the market potential and challenges. Marketers of today are gearing up with new insights, creativity, and analytics to turn business profitable ad meaningful. The Marketing summit aims to tap the creativity aspect of professionals and determine how they can use resources to generate revenue and meet business purpose. How will the leaders adapt to paradigm shift? Evolving role of leaders in different industries, trend identification and strategy, enhancing B2B customer experience and regulatory concerns are the key points event will cover.

Participate and learn from top level executives at MarketsandMarkets Marketing Innovation and Leadership Virtual Summit to be held on October 21-22, 2021!

Our 5th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress to be held on 26 - 29 October 2021 would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

The Artificial Intelligence (AI) market is expected to grow at over `36% to be a $190 Bn market in 2025. Numerous engines are expected to fuel its growth – increase in amount of big data, increased adoption of cloud-based applications and services, increase in demand for virtual assistants, emergence of new use cases as well as others.

From computer vision systems and predictive analytics improving manufacturing operations to self-learning algorithms that help us make better decisions, the AI/ML algorithms will continue to evolve and provide a host of attractive, high growth opportunities. Participants such as CIOs, CTOs, CMOs, AI hardware providers, AI solution and service providers, automation technology providers etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the AI space, as seen through the lens of eminent CXOs in this space.

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference.

The end product sales in bioproduction market are expected to grow at over `15% to be a $305 Bn market in 2025. Numerous engines are expected to fuel its growth – Cell Therapy, Gene Therapy, Monoclonal Antibodies, Vaccines, biosimilars and biobetters, plasma therapy as well as others.

A host of attractive, high growth opportunities such as single use systems, Lab Scale and CGMP manufacturing and R&D, Crispr and other Gene editing tools and technologies, Novel downstream bioprocessing methods etc could be pursued. Participants such as CROs, CMOs, Bioprocess solutions manufacturers, Biobanks, automation technology providers etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the Bioproduction ecosystem, as seen through the lens of eminent CXOs in this space

The blockchain market is expected to grow at over 67% to be a USD 39.7 billion market in 2025. Blockchain is expected to be driven by factors beyond crypto mining such as smart contracts, self-sovereign identity, decentralized storage, and non-fungible tokens.

The blockchain as a service (BaaS) model enables end-users to evaluate the potential of the technology with relatively minimal investment prior investing on the full-fledged on-premise deployment model. BaaS model is attractive among large companies and companies with limited financial strength to test its capabilities for actionable intelligence for real-time decision making. Participants such as CIOs, CTOs, CMOs, AI, Automation, Analytics, IoT solution and service providers, and system integrators can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the blockchain space, as seen through the lens of eminent CXOs in this space.

The businesses have witnessed changes like never before and so do the Marketing world. It has become imperative for professionals to change the way of thinking and analyzing the market potential and challenges. CMO’s of today are gearing up with new insights, creativity, and analytics to turn business profitable ad meaningful.

The big data and analytics market is expected to grow at over `10% to be a USD 229 billion market in 2025. Numerous growth engines are expected to fuel its adoption – the increasing use of Internet of Things (IoT) devices among organizations, increasing availability of data across the organizations to gain deeper insights to remain competitive, and increasing digital transformation initiatives among enterprises.

The adoption of advanced big data technologies with minimal infrastructure, cost-effectiveness offered by the big data solutions, and immediate need for actionable intelligence for enhanced decision-making will provide attractive, high growth opportunities in the big data and analytics market. Participants such as CIOs, CTOs, CMOs, analytics solution and service providers, and system integrators can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the big data  and analytics space, as seen through the lens of eminent CXOs in this space.

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.

Technological innovation influences mission-critical applications in business processes and the manufacturing and technology companies that take the risk and are early adopters of new technology will be rewarded for their progressive decision-making. Since, digitization helps to ensure product quality and safety, as well as faster service delivery, it ensures to go a long way with customers. This has made the IoT adaptation the need of hour!
 

MarketsandMarkets is proud to announce the 3rd Annual MarketsandMarkets World Pharma Supply Chain and Cold Chain Logistics Conference on 21st -22nd June 2022 to be held in Boston, USA.

The event will witness an overwhelming participation of leading supply chain and logistics decision makers.